Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease

BACKGROUND: Fabry disease (FD) is a rare disorder and one of the causes of progressive renal and cardiac dysfunction. FD results from an X-linked recessive lysosomal storage disorder caused by a defect in the gene encoding lysosomal α-galactosidase A. Although accumulation of globotriaosylceramide l...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hideki, Kono, Keiji, Yamamoto, Tetsushi, Onishi, Tetsuari, Goto, Shunsuke, Nakai, Kentaro, Kawai, Hiroya, Hirata, Ken-ichi, Fukagawa, Masafumi, Nishi, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073520/
https://www.ncbi.nlm.nih.gov/pubmed/24976967
http://dx.doi.org/10.1093/ckj/sfs114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073520/
https://www.ncbi.nlm.nih.gov/pubmed/24976967
http://dx.doi.org/10.1093/ckj/sfs114

Ejemplares similares